STAT+: Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that NervGen Pharma (NGENF) hired Daniel Mikol as chief medical officer. Currently, he works at Amgen (AMGN), where he is executive medical director, global clinical development.

Continue to STAT+ to read the full story…